Literature DB >> 17678440

Alzheimer's disease: a lesson from mitochondrial dysfunction.

Paula I Moreira1, Maria S Santos, Catarina R Oliveira.   

Abstract

Extensive literature exists supporting a role for mitochondrial dysfunction and oxidative damage in the pathogenesis of Alzheimer's disease. Mitochondria are a major source of intracellular reactive oxygen species and are particularly vulnerable to oxidative stress. This review discusses evidence supporting the notion that mitochondrial dysfunction is intimately associated with Alzheimer's disease pathogenesis. Furthermore, the potential connection between mitochondrial dysfunction/oxidative stress and autophagy in Alzheimer's disease is also discussed. As a result of insufficient digestion of oxidatively damaged macromolecules and organelles by autophagy, neurons progressively accumulate lipofuscin (biological garbage) that could exacerbate neuronal dysfunction. The knowledge that mitochondrial dysfunction has a preponderant role in several pathological conditions instigated the development of mitochondrial antioxidant therapies. Mitochondria-targeted antioxidant treatments are briefly discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17678440     DOI: 10.1089/ars.2007.1703

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  45 in total

1.  Design and evaluation of multifunctional nanocarriers for selective delivery of coenzyme Q10 to mitochondria.

Authors:  Anjali Sharma; Ghareb M Soliman; Noura Al-Hajaj; Rishi Sharma; Dusica Maysinger; Ashok Kakkar
Journal:  Biomacromolecules       Date:  2011-12-16       Impact factor: 6.988

2.  Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.

Authors:  P Hemachandra Reddy; M Flint Beal
Journal:  Trends Mol Med       Date:  2008-01-22       Impact factor: 11.951

Review 3.  Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

Authors:  Sónia C Correia; Renato X Santos; George Perry; Xiongwei Zhu; Paula I Moreira; Mark A Smith
Journal:  Ageing Res Rev       Date:  2011-01-22       Impact factor: 10.895

4.  Ginsenoside Rg1 attenuates oligomeric Aβ(1-42)-induced mitochondrial dysfunction.

Authors:  Tianwen Huang; Fang Fang; Limin Chen; Yuangui Zhu; Jing Zhang; Xiaochun Chen; Shirley Shidu Yan
Journal:  Curr Alzheimer Res       Date:  2012-03       Impact factor: 3.498

Review 5.  Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention.

Authors:  Yunhua Peng; Peipei Gao; Le Shi; Lei Chen; Jiankang Liu; Jiangang Long
Journal:  Antioxid Redox Signal       Date:  2020-03-16       Impact factor: 8.401

6.  Effect of L-tyrosine in vitro and in vivo on energy metabolism parameters in brain and liver of young rats.

Authors:  Gabriela K Ferreira; Giselli Scaini; Milena Carvalho-Silva; Lara M Gomes; Lislaine S Borges; Júlia S Vieira; Larissa S Constantino; Gustavo C Ferreira; Patrícia F Schuck; Emilio L Streck
Journal:  Neurotox Res       Date:  2012-07-31       Impact factor: 3.911

Review 7.  Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia.

Authors:  Cristina Carvalho; Sónia C Correia; Renato X Santos; Susana Cardoso; Paula I Moreira; Timothy A Clark; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

Review 8.  Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.

Authors:  Anne Eckert; Kathrin L Schulz; Virginie Rhein; Jürgen Götz
Journal:  Mol Neurobiol       Date:  2010-03-09       Impact factor: 5.590

9.  Improved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetam.

Authors:  Kristina Leuner; Christopher Kurz; Giorgio Guidetti; Jean-Marc Orgogozo; Walter E Müller
Journal:  Front Neurosci       Date:  2010-09-07       Impact factor: 4.677

10.  Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice.

Authors:  Virginie Rhein; Xiaomin Song; Andreas Wiesner; Lars M Ittner; Ginette Baysang; Fides Meier; Laurence Ozmen; Horst Bluethmann; Stefan Dröse; Ulrich Brandt; Egemen Savaskan; Christian Czech; Jürgen Götz; Anne Eckert
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.